Study Complete
Sponsor ID
20140409
Long Term Post Marketing Specified Drug Use Result Survey for Evolocumab in Japan
Study Details
The purpose of this post-marketing survey is to obtain real-world information on the safety and effectiveness of evolocumab in Japan.
Protocol Summary
Primary Outcome Measures
Incidence of adverse events and adverse drug reactions
Timeframe: 2 years
Laboratory values for LDL-C
Timeframe: 2 years
Laboratory values for HDL-C
Timeframe: 2 years
Laboratory values for total cholesterol
Timeframe: 2 years
Laboratory values for triglycerides
Timeframe: 2 years
Laboratory values for Apolipoprotein (Apo) A1
Timeframe: 2 years
Laboratory values for Apolipoprotein (Apo) Apo B
Timeframe: 2 years
Laboratory values for Apolipoprotein (Apo) Apo E
Timeframe: 2 years
Laboratory values for lipoprotein(a)
Timeframe: 2 years
Secondary Outcome Measures
Not Available
Locations
Location
Research Site
Uchinada, Ishikawa prefecture, Japan, 920-0293
Status
Not yet recruiting
Location
Research Site
Takasaki, Gunma prefecture, Japan, 370-3513
Status
Recruiting
Location
Research Site
Kahoku gun, Ishikawa prefecture, Japan, 920-0293
Status
Recruiting
Location
Research Site
Ageo city, Saitama prefecture, Japan, 362-8588
Status
Recruiting
Location
Research Site
Chiba City, Chiba prefecture, Japan, 260-8677
Status
Recruiting
Location
Research Site
Takasaki city, Gunma prefecture, Japan, 370-3513
Status
Recruiting
Showing {first} - {last} of {total} Results